Based on X-ray crystallographic analysis of MKC-442/human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) complex, analogues in which the N1-substituent is replaced with ω-functionalized alkyl groups were designed to improve the affinity for the enzyme. Synthesis of these compounds was carried out starting from MKC-442 by a sequence of reactions (N3-protection, removal of N1-ethoxymethyl group, alkylation, and N3-deprotection). The compounds were evaluated for anti-HIV activity. Structure–activity relationships are discussed in terms of the possible interaction with the enzyme.
BabaMTanakaHDe ClercqEPauwelsRBalzariniJScholsDNakashimaHPernoC-FWalkerRT & MiyasakaT (1989) Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Biochemical and Biophysical Research Communications165:1375–1381.
2.
BabaMShigetaSYuasaSTakashimaHSekiyaKUbasawaMTanakaHMiyasakaTWalkerRT & De ClercqE (1994) Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. Antimicrobial Agents and Chemotherapy38:688–692.
3.
BrennanTMTaylorDLBridgesCGLeydaJP & TymsAS (1995) The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds. Antiviral Research26:173–187.
4.
De ClercqE (1996) Non-nucleoside reverse transcriptase inhibitors for the treatment of human immunodeficiency virus type 1 infections: strategies to overcome drug resistance development. Medical Research Reviews16:125–157.
5.
EsnoufRRenJHopkinsARossCJonesEYStammersD & StuartD (1997) Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U90152 explain resistance mutations for this non-nucleoside inhibitor. Proceedings of the National Academy of Sciences, USA94:3984–3989.
6.
HopkinsALRenJEsnoufRMWillcoxBEJonesEYRossCMiyasakaTWalkerRTTanakaHStammersDK & StuartDI (1996) Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. Journal of Medicinal Chemistry39:1589–1600.
7.
JonesT (1985) Interactive computer graphics: FRODO. Methods in Enzymology115:157–171.
8.
KraulisPJ (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. Journal of Applied Crystallography24:946–950.
9.
MerluzziVJHargraveKDLabadiaMGrozingerKSkoogMWuJCShihC-KEcknerKHattoxSAdamsJRosenthalASFaanesREcknerRJKoupRA & SullivanJL (1990) Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science250:1411–1413.
10.
MiyasakaTTanakaHBabaMHayakawaHWalkerRTBalzariniJ & De ClercqE (1989) A new lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. Journal of Medicinal Chemistry32: 2507–2509.
11.
MiyoshiITaguchiHKubonishiIYoshimotoSOhtsukiYShiraishiY & AkagiT (1982) Type C virus producing cell lines derived from adult T cell leukemia. Gann Monographs28:219–228.
12.
PauwelsRDe ClercqEDesmyterJBalzariniJGoubauPHerdewijnPVanderhaegheH & VandeputteM (1987) Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus. Journal of Virological Methods16:171–185.
13.
PauwelsRBalzariniJBabaMSnoeckRScholsDHerdewijnPDesmyterJ & De ClercqE (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods20:309–321.
14.
PauwelsRAndriesKDesmyterJScholsDKuklaMJBreslinHJRaeymaeckersAVan GelderJWoestenborghsRHeykantsJSchellekensKJanssenMACDe ClercqE & JanssenPAJ (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature343:470–474.
15.
TanakaHHayakawaH & MiyasakaT (1993) Lithiation chemistry of uridine derivatives: access to a new anti-HIV-1 lead. In Nucleosides and Nucleotides as Antitumor and Antiviral Agents, pp. 23–53. Edited by ChuCK & BakerDC. New York: Plenum Press.
16.
TanakaHTakashimaHUbasawaMSekiyaKInouyeNBabaMShigetaSWalkerRTDe ClercqE & MiyasakaT (1995) Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. Journal of Medicinal Chemistry38:2860–2865.
17.
WangH & Ben-Naim (1996) A possible involvement of solvent-induced interactions in drug design. Journal of Medicinal Chemistry39:1531–1539.
18.
YuasaSSadakataYTakashimaHSekiyaKInouyeNUbasawaM & BabaM (1993) Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442. Molecular Pharmacology44:895–900.
